Literature DB >> 17681807

Comparative gene expression profiles of intestinal transporters in mice, rats and humans.

Hye-Ryoung Kim1, Sung-Won Park, Hee-Jung Cho, Kyung-Ae Chae, Ji-Min Sung, Jin-Suk Kim, Christopher P Landowski, Duxin Sun, A M Abd El-Aty, Gordon L Amidon, Ho-Chul Shin.   

Abstract

We have studied gene expression profiles of intestinal transporters in model animals and humans. Total RNA was isolated from duodenum and the mRNA expression was measured using Affymetrix GeneChip oligonucleotide arrays. Detected genes from the intestine of mice, rats, and humans were about 60% of 22,690 sequences, 40% of 8739, and 47% of 12,559, respectively. A total of 86 genes involving transporters expressed in mice, 50 genes in rats, and 61 genes in humans were detected. Mice exhibited abundant mRNA expressions for peptide transporter HPT1, amino acid transporters CSNU3, CT1 and ASC1, nucleoside transporter CNT2, organic cation transporter SFXN1, organic anion transporter NBC3, glucose transporter SGLT1, and fatty acid transporters FABP1 and FABP2. Rats showed high expression profiles of peptide transporter PEPT1, amino acid transporters CSNU1 and 4F2HC, nucleoside transporter CNT2, organic cation transporter OCT5, organic anion transporter SDCT1, glucose transporter GLUT2 and GLUT5, and folate carrier FOLT. In humans, the highly expressed genes were peptide transporter HPT1, amino acid transporters LAT3, 4F2HC and PROT, nucleoside transporter CNT2, organic cation transporter OCTN2, organic anion transporters NADC1, NBC1 and SBC2, glucose transporters SGLT1 and GLUT5, multidrug resistance-associated protein RHO12, fatty acid transporters FABP1 and FABP2, and phosphate carrier PHC. Overall these data reveal diverse transcriptomic profiles for intestinal transporters among these species. Therefore, this transcriptional data may lead to more effective use of the laboratory animals as a model for oral drug development.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17681807     DOI: 10.1016/j.phrs.2007.06.005

Source DB:  PubMed          Journal:  Pharmacol Res        ISSN: 1043-6618            Impact factor:   7.658


  20 in total

1.  Reassessment of GLUT7 and GLUT9 as Putative Fructose and Glucose Transporters.

Authors:  Karolin Ebert; Maren Ludwig; Kerstin Elisabeth Geillinger; Gina Catalina Schoberth; Jasmin Essenwanger; Jürgen Stolz; Hannelore Daniel; Heiko Witt
Journal:  J Membr Biol       Date:  2017-01-12       Impact factor: 1.843

2.  Quantitative evaluation of PEPT1 contribution to oral absorption of cephalexin in rats.

Authors:  Takanori Hironaka; Shota Itokawa; Ken-ichi Ogawara; Kazutaka Higaki; Toshikiro Kimura
Journal:  Pharm Res       Date:  2008-09-11       Impact factor: 4.200

3.  Effect of dose escalation on the in vivo oral absorption and disposition of glycylsarcosine in wild-type and Pept1 knockout mice.

Authors:  Dilara Jappar; Yongjun Hu; David E Smith
Journal:  Drug Metab Dispos       Date:  2011-08-31       Impact factor: 3.922

Review 4.  The divergence, actions, roles, and relatives of sodium-coupled bicarbonate transporters.

Authors:  Mark D Parker; Walter F Boron
Journal:  Physiol Rev       Date:  2013-04       Impact factor: 37.312

5.  Mechanisms of gemcitabine oral absorption as determined by in situ intestinal perfusions in mice.

Authors:  Brian R Thompson; Yongjun Hu; David E Smith
Journal:  Biochem Pharmacol       Date:  2019-06-14       Impact factor: 5.858

Review 6.  Glucose transporters in the small intestine in health and disease.

Authors:  Hermann Koepsell
Journal:  Pflugers Arch       Date:  2020-08-23       Impact factor: 3.657

7.  Microarray Determination of the Expression of Drug Transporters in Humans and Animal Species Used for the Investigation of Nasal Absorption.

Authors:  Manar Al-Ghabeish; Todd Scheetz; Mahfoud Assem; Maureen D Donovan
Journal:  Mol Pharm       Date:  2015-07-10       Impact factor: 4.939

8.  Peptide transporter 1 is responsible for intestinal uptake of the dipeptide glycylsarcosine: studies in everted jejunal rings from wild-type and Pept1 null mice.

Authors:  Katherine Ma; Yongjun Hu; David E Smith
Journal:  J Pharm Sci       Date:  2010-09-22       Impact factor: 3.534

Review 9.  Sodium glucose cotransporter SGLT1 as a therapeutic target in diabetes mellitus.

Authors:  Panai Song; Akira Onishi; Hermann Koepsell; Volker Vallon
Journal:  Expert Opin Ther Targets       Date:  2016-04-12       Impact factor: 6.902

10.  Angiotensin II-regulated microRNA 483-3p directly targets multiple components of the renin-angiotensin system.

Authors:  Jacqueline R Kemp; Hamiyet Unal; Russell Desnoyer; Hong Yue; Anushree Bhatnagar; Sadashiva S Karnik
Journal:  J Mol Cell Cardiol       Date:  2014-06-27       Impact factor: 5.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.